About
SandboxAQ is an enterprise quantum AI company spun out from Alphabet in 2022 and based in Palo Alto, California. It applies quantum simulation through its AQBioSim platform to drug discovery, and its Security Suite helps enterprises find and fix cryptographic vulnerabilities ahead of the quantum threat. Partners include Airbus, Deloitte, Mandiant, and US government agencies. The company raised a $450M Series E in 2025 at a $5.3B pre-money valuation, backed by Ray Dalio, Google, NVIDIA, BNP Paribas, and Horizon Kinetics, bringing total funding above $950M. In February 2026 it received a new equity investment from Leclercq American Capital. SandboxAQ's AQNav is the first commercial real-time quantum navigation system to combine AI and quantum sensing. It expanded through the Defense Innovation Unit's Transition of Quantum Sensing program in November 2025, with more than 200 flight hours validated alongside the USAF, Acubed by Airbus, and Boeing. The company won a five-year US Department of Defense contract for enterprise post-quantum cryptography migration services, which also integrates AQNav magnetic navigation into the DoD's Transition of Quantum Sensing program via the Defense Innovation Unit. In July 2025, Airbus tested AQNav software as a GPS backup. SandboxAQ achieved FedRAMP Ready status in December 2025, enabling US federal agency cloud deployments of AQNav, and deployed AQNav in Bahrain with the local government. It was also selected for the NATO DIANA 2025 cohort. In September 2025, SandboxAQ released AQCat25, a public dataset of 11 million high-fidelity quantum chemistry calculations across 40,000 catalyst systems, generated with more than 400,000 GPU-hours on NVIDIA DGX H100, with machine learning inference claimed at 20,000 times faster than physics-based methods. In healthcare, SandboxAQ partnered with iOncologi in July 2025 to develop a personalized mRNA vaccine for glioblastoma, with clinical trials targeted within 18 months, using AQBioSim to des
Quantum Specifications
| Quantum Focus | software |
Funding History
Backed By
Frequently Asked Questions
Related News
SandboxAQ brings its drug discovery models to Claude — no PhD in computing required
Leclercq American Capital Backs SandboxAQ’s Quantum-AI Platform for Cybersecurity & Advanced Simulation
Google moonshot spinout SandboxAQ claims an ex-exec is attempting ‘extortion’
SandboxAQ Deploys AI-Powered Quantum Security Across 60 Bahrain Ministries
SandboxAQ Secures 5-Year Deal to Advance DoW’s Post-Quantum Security
